Within3 Executive Director of Medical Affairs recently shared insights in PharmExec on how and why asynchronous, or over-time, work is transforming workflows for medical affairs teams. It looks clear that a big shift is here to stay.
COVID-19 more clearly focused on the work of some medical affairs and commercial teams because convenience and inclusivity drive high program participation rates, modernizing medical affairs programs and translating directly to downstream insight generation. What were the key benefits realized by this forced transition to an almost all-virtual way of working?
Gains in inclusion, engagements, and insights were driven by the elimination of constraints during a forced shift to asynchronous virtual advisory boards and other types of digital collaboration. Technology is also helping break down geographic constraints, hierarchy influence, cumbersome contribution requirements, and language barriers, all generating meaningful gains in insight generation.
According to Bayer SVP and Head of Medical and Scientific Affairs Shurjeel Choudhri, “By obviating the logistical challenges of getting to and from live events, virtual advisory boards are more accessible.” The digital dimension also delivered additional value. “If anything,” adds Choudhri, “they were much richer than face-to-face meetings.”
Learn more about why asynchronous tactics are a fit for medical affairs workflows – read the article.
